Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06641206Recruiting
Trial of dexmedetomidine in osteoarthritis (OA) (2 arms), sponsored by Tanta University. Primary endpoint: Proportion of patients reporting at least a 50% reduction in pain (measured by Numerical Rating Scale) at 7 months. Started Sep 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06641206.